| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.24 | 1e-06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.23 | 3e-05 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.19 | 0.004 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.096 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.074 | 0.1 |